Statistics

Total Visits

Views
First-line bevacizumab and capecitabine-oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study32

Select a period of time:

Number of views in the range

Views
First-line bevacizumab and capecitabine-oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study17

Views

Views
October 20240
November 20240
December 20240
January 20251
February 20252
March 202514
April 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore14
United States3
 

Top cities views

Views
Dallas1
Huntington Beach1
Pasadena1